[Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO-trial): a phase 3 multicentre stepped-wedge cluster-randomised noninferiority trial].
B J van der Wilk, S S G Gangaram Panday, B M Eyck, S M Lagarde, B P L Wijnhoven, J J B van Lanschot, B Mostert, M C W Spaander, C Rosman, E A Kouwenhoven
Ned Tijdschr Geneeskd 169 D8721
摘要
摘要
OBJECTIVE: To investigate whether active surveillance is non-inferior to standard surgery for patients with a complete clinical response (CCR) after neoadjuvant chemoradiotherapy (nCRT) for oesophageal cancer. DESIGN: A multicentre, stepped-wedge cluster-randomised non-inferiority trial in twelve Dutch hospitals. METHOD: Patients with locally advanced oesophageal cancer and CCR after nCRT (defined by biopsies, endoscopic ultrasound, and PET-CT ) were assigned to active surveillance or standard surgery . The primary endpoint was two-year overall survival. Non-inferiority was defined as ≤15% difference in survival. RESULTS: Of 1,115 screened patients, 309 were included (198 active surveillance, 111 standard surgery). Two-year survival was 74% for active surveillance and 71% for surgery. The hazard ratio for survival was 1.14 (95%-CI: 0.74-1.78). No differences in postoperative complications or mortality were observed. CONCLUSION: Active surveillance is non-inferior to standard surgery after two years for patients with CCR post-nCRT. Further follow-up is needed to confirm long-term efficacy and safety.
KM 提取结果
0 个 Figure · 0 个 KM 面板